Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial
by Fizazi, Karim (Author)
, Retz, Margitta (Author)
, Petrylak, Daniel P. (Author)
, Goh, Jeffrey C. (Author)
, Perez-Gracia, Jose (Author)
, Lacombe, Louis (Author)
, Zschäbitz, Stefanie (Author)
, Burotto, Mauricio (Author)
, Mahammedi, Hakim (Author)
, Gravis, Gwenaelle (Author)
, Bastos, Diogo Assed (Author)
, McCune, Steven L. (Author)
, Limón, Juan Carlos Vázquez (Author)
, Kwan, Edmond M. (Author)
, Castellano, Daniel (Author)
, Fléchon, Aude (Author)
, Saad, Fred (Author)
, Grimm, Marc-Oliver (Author)
, Shaffer, David R. (Author)
, Armstrong, Andrew J. (Author)
, Bhagavatheeswaran, Prabhu (Author)
, Amin, Neha P. (Author)
, Ünsal-Kaçmaz, Keziban (Author)
, Wang, Xuya (Author)
, Li, Jun (Author)
, Loehr, Andrea (Author)
, Pachynski, Russell K. (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource